ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO293

Predialysis Serum Albumin and Hemoglobin and the Risk of Intradialytic Hypotension

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis


  • Curtis, Katherine, Brigham and Women's Hospital Department of Medicine, Boston, Massachusetts, United States
  • Waikar, Sushrut S., Boston Medical Center, Boston, Massachusetts, United States
  • McCausland, Finnian R., Brigham and Women's Hospital Department of Medicine, Boston, Massachusetts, United States

Group or Team Name

  • McCausland Lab.

Intravascular hypovolemia may predispose to intra-dialytic hypotension (IDH), a common occurrence among patients receiving maintenance hemodialysis (HD), which is associated with adverse outcomes. Whether higher pre-HD serum albumin and hemoglobin (Hb), which may reflect hemoconcentration, could serve as biomarkers to predict IDH during an HD session warrants further investigation.


We analyzed data from a prospective cohort study of patients included in the DaVita Biorepository (N=950). Pre-HD serum albumin, hemoglobin, and complete blood pressure (BP) data were available for n=938 patients and n=11,460 sessions. Random-effects Poisson regression models (adjusting for age, sex, race, access type, pre-HD systolic BP (SBP), session length, ultrafiltration, post-HD weight, diabetes mellitus, heart failure, ischemic heart disease, peripheral vascular disease, lung disease) were fit to examine the association of serum albumin and hemoglobin with IDH (defined as minimum SBP <100 if pre-SBP ≥160 or minimum SBP <90 if pre-SBP<160 mmHg).


At baseline, mean age was 58 ±14 years and 44% were female. The mean pre-HD albumin and hemoglobin were 3.5 ±0.5 g/dL and 10.8 ±1.6 g/dL, respectively. A total of 1,606 (14%) sessions were complicated by IDH. Higher pre-HD serum albumin was associated with a 17% higher adjusted risk of IDH (IRR 1.17; 95%CI 1.00, 1.37). Higher Hb (per g/dL) was associated with 6% higher risk of IDH (IRR 1.06; 95%CI 1.02,1.11). When both were considered in the same model, only hemoglobin retained significance (IRR 1.05; 95%CI 1.01, 1.10).


Higher pre-HD serum albumin and hemoglobin were each independently associated with IDH, but only hemoglobin retained significance in a joint-model. Higher hemoglobin may thus serve as a widely-available biomarker to predict IDH at an individual HD-session level.